Inventor · Rockville, MD, US

Daniel Nelson

21Patents
7h-index
13Co-inventors
66Inventor score

Filing activity: Jun 4, 1982 → Oct 31, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US4526770A Method of producing carbon fiber and product thereof Textiles; Paper 20 Expired
US7582291B2 Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria Chemistry; Metallurgy 17 Expired
US7569223B2 Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions Physics 16 Active
US7402309B2 Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions Physics 15 Expired
US6395408B1 Decorative laminate incorporating photoluminescent material Emerging Cross-Sectional Technologies 12 Expired
US5597611A Reinforced carbon composites Emerging Cross-Sectional Technologies 9 Expired
US6833262B1 Polypeptide having amidolytic activity for a serpin Human Necessities 8 Expired
US4776995A Method of making a structure Textiles; Paper 6 Expired
US6608187B2 C1 bacteriophage lytic system Chemistry; Metallurgy 6 Expired
US5773122A Reinforced carbon composites Emerging Cross-Sectional Technologies 5 Expired
US4777093A High carbon composite Emerging Cross-Sectional Technologies 5 Expired
USD806407S1 Collapsible tie rack General 5 Active
US6596416B2 Decorative laminate incorporating photoluminescent material Emerging Cross-Sectional Technologies 4 Expired
US9872893B2 Endolysins active against Staphylococcus bacteria, pharmaceutical compositions, and methods relating thereto Chemistry; Metallurgy 3 Active
US4776994A Method of making a structure from carbonaceous fibers Chemistry; Metallurgy 3 Expired
US7838255B2 Nucleic acids and polypeptides of C1 bacteriophage and uses thereof Human Necessities 2 Active
US8389469B2 Bacteriophage lysins for Bacillus anthracis Human Necessities 2 Active
US7582729B2 Nucleic acids and polypeptides of C1 bacteriophage and uses thereof Human Necessities 2 Expired
US8580553B2 Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions Physics 0 Active
US10975365B2 Di-enzymatic chimeric endolysin Emerging Cross-Sectional Technologies 0 Active
US11890330B2 Endolysins active against Bacillus bacteria, pharmaceutical compositions, and methods relating thereto Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.